We invest in software-based companies (Healthcare IT, tech-enabled services) operating in the US market and focus on B2B or B2B2C companies. We look for products that solve a real unmet need and have clear cost-saving or revenue-generating aspects. We seek to leverage Arkin’s extensive cross-sector exposure, especially in the crossroads between pharmaceutical/biotech, devices, and digital health to support our portfolio companies and create new value propositions.